Malaria: genes and variants
Explore variant evidence for Malaria across 4 analyzed proteins (G6PD, HBB, TLR7, TLR9). Linked ClinVar records include 28 pathogenic or likely pathogenic variants, 3 variants of uncertain significance and 9 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Malaria
G6PD: Glucose-6-phosphate 1-dehydrogenase
It generates NADPH through the pentose-phosphate pathway, providing red blood cells with the reducing power needed to withstand oxidative stress. Deficiency can trigger neonatal jaundice or acute hemolytic anemia after infections, fava beans, or oxidant drugs.
26 ClinVar pathogenic / likely pathogenic and 6 uncertain variants in G6PD have source records linked to Malaria. Association strength is not clinical gene validity.
HBB: Hemoglobin subunit beta
Beta-globin, one of the two major protein chains in adult hemoglobin. Hemoglobin uses these chains to transport oxygen from the lungs to tissues, and HBB variants are associated with sickle-cell disease and beta-thalassemia.
2 ClinVar pathogenic / likely pathogenic and 4 uncertain variants in HBB have source records linked to Malaria. Association strength is not clinical gene validity.
TLR7: Toll-like receptor 7
It detects single-stranded viral RNA in endosomes and drives type I interferon and inflammatory responses, particularly in plasmacytoid dendritic cells and B cells. Loss-of-function variants can predispose to severe viral infection, whereas gain-of-function variants cause immune dysregulation and autoimmunity.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TLR7 have source records linked to Malaria. Association strength is not clinical gene validity.
TLR9: Toll-like receptor 9
It detects unmethylated CpG-rich DNA in endosomes and activates innate immune and type I interferon responses. Dysregulated signaling can contribute to autoimmunity, while agonists and antagonists of the pathway are being developed for cancer and inflammatory disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TLR9 have source records linked to Malaria. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): SLC4A1.
ClinVar pathogenic and likely pathogenic variants linked to Malaria
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| G6PD R166H | 166 | Pathogenic / likely pathogenic (★★) | |
| G6PD R166C | 166 | Pathogenic / likely pathogenic (★★) | |
| G6PD R198C | 198 | Pathogenic / likely pathogenic (★★) | |
| G6PD R198H | 198 | Pathogenic / likely pathogenic (★★) | |
| G6PD A335D | 335 | Pathogenic / likely pathogenic (★★) | |
| G6PD A44G | 44 | Pathogenic / likely pathogenic (★★) | |
| G6PD R136C | 136 | Pathogenic / likely pathogenic (★★) | |
| G6PD G163S | 163 | Pathogenic / likely pathogenic (★★) | |
| G6PD A335V | 335 | Pathogenic / likely pathogenic (★★) | |
| G6PD N165D | 165 | Pathogenic / likely pathogenic (★★) | |
| G6PD H32R | 32 | Pathogenic / likely pathogenic (★★) | |
| G6PD I48T | 48 | Pathogenic / likely pathogenic (★★) | |
| G6PD G131V | 131 | Pathogenic / likely pathogenic (★★) | |
| G6PD L137F | 137 | Pathogenic / likely pathogenic (★★) | |
| G6PD F173L | 173 | Pathogenic / likely pathogenic (★★) | |
| G6PD D282H | 282 | Pathogenic / likely pathogenic (★★) | |
| G6PD R285H | 285 | Pathogenic / likely pathogenic (★★) | |
| G6PD L323P | 323 | Pathogenic / likely pathogenic (★★) | |
| G6PD R387H | 387 | Pathogenic / likely pathogenic (★★) | |
| G6PD R463C | 463 | Pathogenic / likely pathogenic (★★) | |
| G6PD E317K | 317 | Pathogenic / likely pathogenic (★★) | |
| G6PD G447R | 447 | Pathogenic / likely pathogenic (★★) | |
| HBB N109K | 109 | Globin | Pathogenic / likely pathogenic (★★) |
| HBB Y146N | 146 | Globin | Pathogenic / likely pathogenic (★★) |
| G6PD D181V | 181 | Pathogenic / likely pathogenic (★★) | |
| G6PD R227G | 227 | Pathogenic / likely pathogenic (★) | |
| G6PD R257G | 257 | Pathogenic / likely pathogenic (★) | |
| G6PD A335T | 335 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Malaria
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| G6PD R136H | 136 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R136C at the same position is pathogenic; REVEL 0.837 |
Which prediction tools work for Malaria
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 94 out of 100
- PolyPhen-2: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 87 out of 100
- ESM1b (LLR): 86 out of 100
- CATVariant: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 85 out of 100
- SIFT: 79 out of 100
- SpliceAI: 58 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 33 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Anemia, nonspherocytic hemolytic, due to G6PD deficiency also has ClinVar records linked to G6PD variants; they fall mostly in different places as the Malaria variants (182 pathogenic / likely pathogenic).
- G6PD deficiency also has ClinVar records linked to G6PD variants; they fall partly in the same places as the Malaria variants (11 pathogenic / likely pathogenic).
- Familial erythrocytosis also has ClinVar records linked to HBB variants; they fall mostly in different places as the Malaria variants (31 pathogenic / likely pathogenic).
- Beta thalassemia also has ClinVar records linked to HBB variants; they fall mostly in different places as the Malaria variants (21 pathogenic / likely pathogenic).
- Beta-thalassemia HBB/LCRB also has ClinVar records linked to HBB variants; they fall mostly in different places as the Malaria variants (18 pathogenic / likely pathogenic).
- Heinz body anemia also has ClinVar records linked to HBB variants; they fall mostly in different places as the Malaria variants (12 pathogenic / likely pathogenic).
- Hemoglobinopathy also has ClinVar records linked to HBB variants; they fall mostly in different places as the Malaria variants (12 pathogenic / likely pathogenic).
Diseases related to Malaria
- Systemic lupus erythematosus, also linked to TLR7 and TLR9
- Anemia, nonspherocytic hemolytic, due to G6PD deficiency, also linked to G6PD
- Familial erythrocytosis, also linked to HBB
- Beta thalassemia, also linked to HBB
- Heinz body anemia, also linked to HBB
- Atypical hemolytic-uremic syndrome, also linked to HBB
- Beta-thalassemia HBB/LCRB, also linked to HBB
- Hemoglobinopathy, also linked to HBB
- G6PD deficiency, also linked to G6PD
- Dominant beta-thalassemia, also linked to HBB
- Alpha Thalassemia, also linked to HBB
- Hemoglobin M disease, also linked to HBB
Frequently asked questions
Which genes have records linked to Malaria?
This view contains 4 analyzed proteins: G6PD, HBB, TLR7, TLR9. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 28 pathogenic or likely pathogenic variants, 3 variants of uncertain significance and 9 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 40 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center